Specificity of treatment is mandatory in very old patients with hairy cell leukemia

Vojnosanit Pregl. 2015 May;72(5):466-8. doi: 10.2298/vsp1505466m.

Abstract

Introduction: There are only a few available data about hairy cell leukemia (HCL) in very old patients. We presented three very different cases of HCL in very old patients diagnosed in a single center and discussed some epidemiological and therapeutical issues in such patients.

Case report: The first patient, 89-year-old, had symptomatic cytopenia and achieved sustained complete remission after cladribine treatment. The second patient, 89-year-old, had asymptomatic disease with stable full blood counts during a 3-year follow-up period in which watch-and-wait policy was adopted. The third patient, 82 years old, had two malignancies (HCL and presumably metas- tatic colorectal carcinoma) and his only treatment were occasional red blood cell transfusions and symptomatic therapy.

Conclusion: The presented illustrative examples confirm individualization of treatment is mandatory in very old patients with HCL.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Anemia / etiology
  • Anemia / therapy*
  • Antineoplastic Agents / therapeutic use*
  • Cladribine / therapeutic use*
  • Erythrocyte Transfusion
  • Humans
  • Leukemia, Hairy Cell / complications
  • Leukemia, Hairy Cell / therapy*
  • Male
  • Precision Medicine
  • Watchful Waiting / methods*

Substances

  • Antineoplastic Agents
  • Cladribine